Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
5,900
Employees5,900
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
5,900
Employees5,900

MEDP Key Statistics

Market cap
17.63B
Market cap17.63B
Price-Earnings ratio
43.11
Price-Earnings ratio43.11
Dividend yield
Dividend yield
Average volume
212.75K
Average volume212.75K
High today
$628.92
High today$628.92
Low today
$611.53
Low today$611.53
Open price
$618.04
Open price$618.04
Volume
33.59K
Volume33.59K
52 Week high
$628.92
52 Week high$628.92
52 Week low
$250.05
52 Week low$250.05

Stock Snapshot

The current Medpace(MEDP) stock price is $625.99, with a market capitalization of 17.63B. The stock trades at a price-to-earnings (P/E) ratio of 43.11.

On 2026-01-16, Medpace(MEDP) stock moved within a range of $611.53 to $628.92. With shares now at $625.99, the stock is trading +2.4% above its intraday low and -0.5% below the session's peak.

Trading volume for Medpace(MEDP) stock has reached 33.59K, versus its average volume of 212.75K.

The stock's 52-week range extends from a low of $250.05 to a high of $628.92.

The stock's 52-week range extends from a low of $250.05 to a high of $628.92.

MEDP News

Simply Wall St 1d
Will Medpace's AI-Powered Clinical Trials and Digital Tools Shift Medpace Holdings' Narrative?

Recently, Medpace Holdings was highlighted for its role in outsourced clinical trials and medical research, with analysts pointing to strong organic growth and...

Will Medpace's AI-Powered Clinical Trials and Digital Tools Shift Medpace Holdings' Narrative?
Investor's Business Daily 3d
IBD Stock Of The Day Medpace Tests Early Buy Point As Biotech Funding Shines

Medpace Holdings Medpace Holdings MEDP $ 610.15 $10.94 1.83% 25% IBD Stock Analysis Stock eyeing 626.25 buy point, testing 614.36 early entry MEDP posted 3 quar...

IBD Stock Of The Day Medpace Tests Early Buy Point As Biotech Funding Shines

Analyst ratings

60%

of 15 ratings
Buy
6.7%
Hold
60%
Sell
33.3%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .